Medilux Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth %
- Ebitda
- Net Worth
- Total Assets 10.85%
About Medilux Healthcare
Medilux Healthcare Private Limited (MHPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 August 2011 and has a history of 13 years and five months. Its registered office is in Indore, Madhya Pradesh, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Deepak Kewalramani and Sanjay Kewalramani serve as directors at the Company.
Company Details
-
Location
Indore, Madhya Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232MP2011PTC026539
-
Company No.
026539
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
08 Aug 2011
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Medilux Healthcare?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Kewalramani
|
Director | 08-Aug-2011 | Current |
|
Deepak Kewalramani
|
Director | 08-Aug-2011 | Current |
Financial Performance of Medilux Healthcare.
Medilux Healthcare Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medilux Healthcare?
In 2017, Medilux Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Medilux Laboratories Pvt LtdDeepak Kewalramani and Sanjay Kewalramani are mutual person
-
Medilux Diagnostics Private Limited
Deepak Kewalramani and Sanjay Kewalramani are mutual person
-
Medilux Drugs Private Limited
Sanjay Kewalramani is a mutual person
-
Medilux Chemicals Private Limited
Sanjay Kewalramani is a mutual person
-
Medilux Pharma LlpDeepak Kewalramani and Sanjay Kewalramani are mutual person
-
Deepaksan Tradex Llp
Deepak Kewalramani and Sanjay Kewalramani are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medilux Healthcare?
Unlock and access historical data on people associated with Medilux Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medilux Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medilux Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.